HIMACS (4299) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
20 Jul, 2026Executive summary
Net sales rose 1.7% year-over-year to ¥8,816 million for the six months ended September 30, 2024.
Operating profit increased 14.3% year-over-year to ¥804 million, with ordinary profit up 14.9% to ¥811 million.
Profit attributable to owners of parent grew 15.0% year-over-year to ¥554 million.
Earnings per share increased to ¥47.86 from ¥41.37 in the prior year period.
Financial highlights
Gross profit improved to ¥1,805 million from ¥1,715 million year-over-year.
Selling, general and administrative expenses remained stable at ¥1,002 million.
Comprehensive income rose to ¥545 million from ¥494 million year-over-year.
Cash and deposits at period end were ¥9,790 million, up from ¥9,846 million at the previous fiscal year end.
Net assets increased to ¥11,266 million, with an equity ratio of 81.8%.
Outlook and guidance
Full-year net sales forecasted at ¥18,600 million, up 7.2% year-over-year.
Operating profit projected at ¥1,780 million, ordinary profit at ¥1,790 million, and profit attributable to owners of parent at ¥1,220 million.
Full-year earnings per share expected to reach ¥105.32.
Annual dividend forecast set at ¥44.00 per share.
Latest events from HIMACS
- Stable sales and profit growth with positive full-year outlook and robust equity position.4299
Q1 202520 Jul 2026 - Sales and profits rose, with FY2026 sales growth forecast but lower net profit expected.4299
Q4 202520 Jul 2026 - Profits and sales rose year-over-year, with a higher full-year outlook and dividend forecast.4299
Q3 202520 Jul 2026 - Sales rose, but profits fell sharply; full-year outlook sees higher revenue but lower net income.4299
Q1 202620 Jul 2026 - Sales rose modestly, but profits declined; full-year outlook expects higher sales and stable margins.4299
Q2 202620 Jul 2026 - Revenue grew slightly, but profits and cash reserves declined due to higher expenses and share buybacks.4299
Q3 202620 Jul 2026 - Sales rose modestly, but profits fell and next year's earnings are forecast to decline further.4299
Q4 202620 Jul 2026